1. Home
  2. BTOC vs ACXP Comparison

BTOC vs ACXP Comparison

Compare BTOC & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

N/A

Current Price

$1.91

Market Cap

4.9M

Sector

N/A

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

N/A

Current Price

$1.05

Market Cap

5.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTOC
ACXP
Founded
2020
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BTOC
ACXP
Price
$1.91
$1.05
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
43.6K
★ 94.2K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $185,835,053.00
N/A
Revenue This Year
$55.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.15
$0.90
52 Week High
$11.49
$7.54

Technical Indicators

Market Signals
Indicator
BTOC
ACXP
Relative Strength Index (RSI) 44.13 46.16
Support Level $0.15 $0.95
Resistance Level $5.29 $1.12
Average True Range (ATR) 0.33 0.09
MACD 0.05 0.01
Stochastic Oscillator 14.09 62.81

Price Performance

Historical Comparison
BTOC
ACXP

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: